Related references
Note: Only part of the references are listed.Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection
Chen-Ta Chi et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Progress and prospects of biomarkers in primary liver cancer (Review)
Yu-Xue Gao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
Gang Wang et al.
CELL DEATH & DISEASE (2020)
The role of long noncoding RNAs in hepatocellular carcinoma
Zhao Huang et al.
MOLECULAR CANCER (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging
Sun Kyung Jeon et al.
EUROPEAN RADIOLOGY (2019)
Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
Nancy M. Joseph et al.
JOURNAL OF PATHOLOGY (2019)
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
Jiakun Wang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Ruidong Xue et al.
CANCER CELL (2019)
Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma
Jiajia He et al.
CANCER LETTERS (2019)
Lenvatinib (len) plus pembrolizumab (pembro) for the first-line treatment of patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 3 LEAP-002 study.
Josep M. Llovet et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The Worst from Both Worlds: cHCC-ICC
Marco Seehawer et al.
CANCER CELL (2019)
Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma
Dana Balitzer et al.
MODERN PATHOLOGY (2019)
The jigsaw of dual hepatocellular-intrahepatic cholangiocarcinoma tumours
Patricia Munoz-Garrido et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma
Elia Gigante et al.
LIVER INTERNATIONAL (2019)
Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade
Xiaoliang Liu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
T Yau et al.
ANNALS OF ONCOLOGY (2019)
An exceptional response to immunotherapy doublet in combined hepatocellular carcinoma-cholangiocarcinoma
E. Tahover
ANNALS OF ONCOLOGY (2019)
The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development
Fengru Jiang et al.
JOURNAL OF CANCER (2019)
Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
Chara Stavraka et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2019)
Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature
Yuka Futsukaichi et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2019)
Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity
Zhen-Hao Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
Ming-Chun Ma et al.
BMC CANCER (2018)
Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
Satoshi Kobayashi et al.
CANCER SCIENCE (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
Elizabeth Brunt et al.
HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma
Chaobin He et al.
ONCOLOGY LETTERS (2018)
Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
Anqiang Wang et al.
NATURE COMMUNICATIONS (2018)
A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications
Xiaoge Hu et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Vogel et al.
ANNALS OF ONCOLOGY (2018)
Necroptosis microenvironment directs lineage commitment in liver cancer
Marco Seehawer et al.
NATURE (2018)
De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation
Johanna R. Schaub et al.
NATURE (2018)
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
Victoria Chernyak et al.
RADIOLOGY (2018)
Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience
Nikolaos A. Trikalinos et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre
Venkata Pradeep K. Babu et al.
INDIAN JOURNAL OF CANCER (2018)
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study
Maeva Salimon et al.
BRITISH JOURNAL OF CANCER (2018)
Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance
Motoko Sasaki et al.
HISTOPATHOLOGY (2017)
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
Agrin Moeini et al.
JOURNAL OF HEPATOLOGY (2017)
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma
Gaya Spolverato et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Farshad Farshidfar et al.
CELL REPORTS (2017)
748TiPABC-06: A RANDOMISED PHASE III, MULTI-CENTRE, OPEN-LABEL STUDY OF ACTIVE SYMPTOM CONTROL (ASC) ALONE OR ASC WITH OXALIPLATIN / 5-FU CHEMOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED / METASTATIC BILIARY TRACT CANCERS (ABC) PREVIOUSLY TREATED WITH CISPLATIN / GEMCITABINE CHEMOTHERAPY.
A. Lamarca et al.
ANNALS OF ONCOLOGY (2017)
Clinical features, histology, and histogenesis of combined hepatocellular- cholangiocarcinoma
Shweta Gera et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes
Paolo Magistri et al.
DIGESTIVE AND LIVER DISEASE (2017)
Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Young-In Yoon et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases
Theodora A. Potretzke et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2016)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography
Rui Li et al.
BMC CANCER (2016)
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
Joseph Ciccolini et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics
John R. Bergquist et al.
HPB (2016)
Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy
Kathryn Fowler et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease
Angela Lamarca et al.
EUROPEAN JOURNAL OF CANCER (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
Akihiro Fujimoto et al.
NATURE COMMUNICATIONS (2015)
Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma
Motoko Sasaki et al.
LIVER INTERNATIONAL (2015)
Functional and genetic deconstruction of the cellular origin in liver cancer
Jens U. Marquardt et al.
NATURE REVIEWS CANCER (2015)
Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress
Elizabeth M. Brunt et al.
HEPATIC ONCOLOGY (2015)
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma
Anup S. Shetty et al.
ABDOMINAL IMAGING (2014)
Combined Hepatocellular-Cholangiocarcinoma: A Population-Level Analysis of an Uncommon Primary Liver Tumor
Mattia Garancini et al.
LIVER TRANSPLANTATION (2014)
Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification
Jun Akiba et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma
Ryan T. Groeschl et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Validation of Organ Procurement and Transplant Network (OPTN)/United Network for Organ Sharing (UNOS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma
Kathryn J. Fowler et al.
TRANSPLANTATION (2013)
Long-Term Outcome of Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Y. -H. Park et al.
TRANSPLANTATION PROCEEDINGS (2013)
Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis
Xin Yin et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways
Cedric Coulouarn et al.
CARCINOGENESIS (2012)
Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma
Huey-Ling You et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Differentiating Combined Hepatocellular and Cholangioc cinoma from Mass-Forming Intrahepatic Chol gioc cinoma Using Gadoxetic Acid-Enh ced MRI
Jiyoung Hwang et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Combined hepatocellular carcinoma-cholangiocarcinoma: Report of MR appearance in eleven patients
Rafael O. P. de Campos et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Pathology of combined hepatocellular-cholangiocarcinoma
Matthew M. Yeh
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
Jue Wang et al.
JOURNAL OF ONCOLOGY (2010)
Surgical Treatments and Prognoses of Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Ki Hun Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma
Spiros G. Delis et al.
HPB (2009)
Management of combined hepatocellular and cholangiocarcinoma
W. T. Kassahun et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
S. A. Khan et al.
HPB (2008)
Clinical evaluation of lens culinaris agglutinin-reactive α-fetoprotein and des-γ-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States
Brian I. Carr et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: A comparative study with hepatocellular carcinoma and cholangiocellular carcinoma
Di Tang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma - Assessment of enhancement patterns on dynamics computed tomography before resection
Y Sanada et al.
HEPATOLOGY RESEARCH (2005)
Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: Comparison with histologic findings
A Nishie et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas
D Cazals-Hatem et al.
JOURNAL OF HEPATOLOGY (2004)
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases
Y Yano et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
Hepatocellular-cholangiocarcinoma: Helical computed tomography findings in 30 patients
O Ebied et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2003)
Hepatic resection for combined hepatocellular and cholangiocarcinoma
CL Liu et al.
ARCHIVES OF SURGERY (2003)
Combined hepatocellular and cholangiocarcinoma - Demographic, clinical, and prognostic factors
WR Jarnagin et al.
CANCER (2002)
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565
AP Venook et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
